Browse by Journal Title

2021

Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC)-derived sensory neurons.
Schinke, C., Vallone, V.F., Ivanov, A., Peng, Y., Körtvelyessy, P., Nolte, L., Huehnchen, P., Beule, D., Stachelscheid, H., Boehmerle, W. and Endres, M.
Neurobiology of Disease 155 : 105391. July 2021

2020

Neurofibromatosis 1 - mutant microglia exhibit sexually-dimorphic cyclic AMP-dependent purinergic defects.
Elmadany, N., Logiacco, F., Buonfiglioli, A., Haage, V., Wright-Jin, E.C., Schattenberg, A., Papawassiliou, R., Kettenmann, H., Semtner, M. and Gutmann, D.H.
Neurobiology of Disease 144 : 105030. October 2020

2017

Epigenetics of cell fate reprogramming and its implications for neurological disorders modelling.
Grzybek, M., Golonko, A., Walczak, M. and Lisowski, P.
Neurobiology of Disease 99 : 84-120. March 2017

2016

Loss of DJ-1 impairs antioxidant response by altered glutamine and serine metabolism.
Meiser, J., Delcambre, S., Wegner, A., Jaeger, C., Ghelfi, J., D'Herouel, A.F., Dong, X., Weindl, D., Stautner, C., Nonnenmacher, Y., Michelucci, A., Popp, O., Giesert, F., Schildknecht, S., Kraemer, L., Schneider, J.G., Woitalla, D., Wurst, W., Skupin, A., Weisenhorn, D.M.V., Krueger, R., Leist, M. and Hiller, K.
Neurobiology of Disease 89 : 112-125. May 2016

2014

Exonic microdeletions of the gephyrin gene impair GABAergic synaptic inhibition in patients with idiopathic generalized epilepsy.
Dejanovic, B., Lal, D., Catarino, C.B., Arjune, S., Belaidi, A.A., Trucks, H., Vollmar, C., Surges, R., Kunz, W.S., Motameny, S., Altmüller, J., Köhler, A., Neubauer, B.A., Nürnberg, P., Noachtar, S., Schwarz, G. and Sander, T.
Neurobiology of Disease 67 : 88-96. July 2014

2010

L1 syndrome mutations impair neuronal L1 function at different levels by divergent mechanisms.
Schaefer, M.K.E., Nam, Y.C., Moumen, A., Keglowich, L., Bouche, E., Kueffner, M., Bock, H.H., Rathjen, F.G., Raoul, C. and Frotscher, M.
Neurobiology of Disease 40 (1): 222-237. October 2010

2007

Increased inhibitory input to CA1 pyramidal cells alters hippocampal gamma frequency oscillations in the MK-801 model of acute psychosis.
Kehrer, C., Dugladze, T., Maziashvili, N., Wojtowicz, A., Schmitz, D., Heinemann, U. and Gloveli, T.
Neurobiology of Disease 25 (3): 545-552. March 2007

2006

Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage.
Prigione, A., Begni, B., Galbussera, A., Beretta, S., Brighina, L., Garofalo, R., Andreoni, S., Piolti, R. and Ferrarese, C.
Neurobiology of Disease 23 (1): 36-43. July 2006

Proliferative response of distinct hippocampal progenitor cell populations after cortical infarcts in the adult brain.
Kunze, A., Grass, S., Witte, O.W., Yamaguchi, M., Kempermann, G. and Redecker, C.
Neurobiology of Disease 21 (2): 324-332. February 2006

Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease.
Hockly, E., Tse, J., Barker, A.L., Moolman, D.L., Beunard, J.L., Revington, A.P., Holt, K., Sunshine, S., Moffitt, H., Sathasivam, K., Woodman, B., Wanker, E.E., Lowden, P.A. and Bates, G.P.
Neurobiology of Disease 21 (1): 228-236. January 2006

2005

Estrogen suppresses the impact of glucose deprivation on astrocytic calcium levels and signaling independently of the nuclear estrogen receptor.
Arnold, S.
Neurobiology of Disease 20 (1): 82-92. October 2005

The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits.
Bertrand, D., Elmslie, F., Hughes, E., Trounce, J., Sander, T., Bertrand, S. and Steinlein, O.K.
Neurobiology of Disease 20 (3): 799-804. 17 June 2005